Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will lead Resmed’s global investor relations function and report to Mick Farrell, CEO. Schwartz joins Resmed from Illumina, where she served as the Head of Investor Relations.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RMD:
- ResMed price target lowered to $268 from $280 at KeyBanc
- RMD Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- ResMed price target lowered to $265 from $280 at Mizuho
- Resmed’s Strong Financial Performance and Strategic Growth Drive Buy Rating
- Positive Outlook for Resmed Inc: Buy Rating Despite Short-Term Challenges